ConductScience.org, home

Paper35680378

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.

Traber GM and 1 other. J Pharmacol Exp Ther, 2023. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. Papers, record 35680378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35680378

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
26.2
iCite
Revised in PubMed
2025-07-22
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Traber GMGavin M
2Yu AMAi-Ming

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Biological ProductsMajor topic
RNA Interference
RNAi Therapeutics
RNA, Small Interfering
Bioengineering

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA093373NCI NIH HHSUnited StatesP30CA093373PubMed and NIHNIH RePORTER
T32 GM144303NIGMS NIH HHSUnited StatesT32GM144303PubMedNIH RePORTER
R01 CA225958NCI NIH HHSUnited StatesR01CA225958PubMed and NIHNIH RePORTER
T32 GM099608NIGMS NIH HHSUnited StatesT32GM099608PubMed and NIHNIH RePORTER
R35 GM140835NIGMS NIH HHSUnited StatesR35GM140835PubMed and NIHNIH RePORTER
R01 CA253230NCI NIH HHSUnited StatesR01CA253230PubMed and NIHNIH RePORTER

Download CSV of grants

References260

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135326738Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine.Cancers (Basel)2022https://conductscience.org/library/papers/35326738PubMed
226756051Preface.Methods Mol Biol2016https://conductscience.org/library/papers/26756051PubMed
327432743An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.J Am Soc Nephrol2017https://conductscience.org/library/papers/27432743PubMed
432187462Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.N Engl J Med2020https://conductscience.org/library/papers/32187462PubMed
523982190Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier.Mol Ther Nucleic Acids2013https://conductscience.org/library/papers/23982190PubMed
628415566Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models.Oncotarget2017https://conductscience.org/library/papers/28415566PubMed
729280958Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.Int J Mol Sci2017https://conductscience.org/library/papers/29280958PubMed
822610888MiR-122 in hepatic function and liver diseases.Protein Cell2012https://conductscience.org/library/papers/22610888PubMed
932238921Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.Br J Cancer2020https://conductscience.org/library/papers/32238921PubMed
1020347954Identification of homologous microRNAs in 56 animal genomes.Genomics2010https://conductscience.org/library/papers/20347954PubMed
1125161167Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells.Drug Metab Dispos2014https://conductscience.org/library/papers/25161167PubMed
1233277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
1316672282Characterization of extracellular RNAs produced by the marine photosynthetic bacterium Rhodovulum sulfidophilum.J Biochem2006https://conductscience.org/library/papers/16672282PubMed
1428202367Exosomes: Therapy delivery tools and biomarkers of diseases.Pharmacol Ther2017https://conductscience.org/library/papers/28202367PubMed
15175795742'-O-methyl-modified RNAs act as TLR7 antagonists.Mol Ther2007https://conductscience.org/library/papers/17579574PubMed
1633405070Lumasiran: First Approval.Drugs2021https://conductscience.org/library/papers/33405070PubMed
1732539351Investigational Therapies for Primary Hyperoxaluria.Bioconjug Chem2020https://conductscience.org/library/papers/32539351PubMed
1828854095Porphyria.N Engl J Med2017https://conductscience.org/library/papers/28854095PubMed
1916816104A brief history of RNAi: the silence of the genes.FASEB J2006https://conductscience.org/library/papers/16816104PubMed
2019239886Origins and Mechanisms of miRNAs and siRNAs.Cell2009https://conductscience.org/library/papers/19239886PubMed

See all 260 referencesDownload CSV of references

Cited by168

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
42921028Structural and Combinatorial Design Principles of Emerging Drug Carriers.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42921028PubMed
42890564Nucleic acids in medicinal plants and their pharmaceutical potential.Extracell Vesicles Circ Nucl Acids2026https://conductscience.org/library/papers/42890564PubMed
42761173Gene therapy for hereditary hematological disorders: From clinical breakthroughs to future horizons.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42761173PubMed
42653709Targeting Immune Checkpoint Proteins in Cancer Therapy and the Potential of RNAi-Based Immunotherapy.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653709PubMed
42652989Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations.Life (Basel)2026https://conductscience.org/library/papers/42652989PubMed
42651807Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42651807PubMed
42647067Medicinal and Crop Protection Chemistry: Breaking Barriers, Building Synergies.ChemMedChem2026https://conductscience.org/library/papers/42647067PubMed
42646357Efficacy of Bioengineered PD-L1 siRNA for Immunotherapy Against Non-Small Cell Lung Cancer Cells.Noncoding RNA2026https://conductscience.org/library/papers/42646357PubMed
42629543Milk derived exosomes sensitize Gefitinib-resistant lung cancer cells to Pemetrexed via CAV1-mediated endocytosis.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42629543PubMed
42505414LncRNA NR_003508 Boosts Pseudomonas aeruginosa-Induced Autophagy by Facilitating the Conversion of LC3-I to LC3-II and p62 Degradation.Cells2026https://conductscience.org/library/papers/42505414PubMed
42486096Fatty-acid-based antimiR-23b delivery in the DMSXL model: A potential therapeutic strategy for brain dysfunction in myotonic dystrophy type 1.Cell Rep Med2026https://conductscience.org/library/papers/42486096PubMed
42482156miR-335-3p acts as a tumor suppressor in esophageal squamous cell carcinoma and predicts favorable prognosis.Hereditas2026https://conductscience.org/library/papers/42482156PubMed
42395640Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transporters.Liver Res2026https://conductscience.org/library/papers/42395640PubMed
42381703Milk-derived extracellular vesicles loaded with miR-146a-5p as a novel therapeutic strategy for allergic airway inflammation.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42381703PubMed
42373233Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention.Cancer Genomics Proteomics2026https://conductscience.org/library/papers/42373233PubMed
42368742Bovine Milk-Derived Extracellular Vesicles as Emerging Drug Delivery Platforms: Current Advances, Applications and Challenges.J Extracell Biol2026https://conductscience.org/library/papers/42368742PubMed
42356544The Role and Therapeutic Potential of the STING Signaling Pathway in the Pathogenesis of Diabetic Nephropathy.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356544PubMed
42293824miR-1251-5p inhibits tumorigenesis and metastasis in renal cell carcinoma by targeting MTHFD2.Transl Androl Urol2026https://conductscience.org/library/papers/42293824PubMed
42218706Small interfering RNA (siRNA)-based targeting breast cancer therapy.Discov Oncol2026https://conductscience.org/library/papers/42218706PubMed
42192969miRNA-lncRNA Cross-Regulation Landscape in Cancer: From Molecular Mechanisms to Therapeutic and Diagnostic Applications.Cancers (Basel)2026https://conductscience.org/library/papers/42192969PubMed

See all 168 cited byDownload CSV of cited by

Genes41

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALAS1211PubTator's text mininghttps://conductscience.org/library/genes/211NCBI Gene
ASGR1432PubTator's text mininghttps://conductscience.org/library/genes/432NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
CDK61021PubTator's text mininghttps://conductscience.org/library/genes/1021NCBI Gene
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
DGCR854487PubTator's text mininghttps://conductscience.org/library/genes/54487NCBI Gene
DICER123405PubTator's text mininghttps://conductscience.org/library/genes/23405NCBI Gene
DROSHA29102PubTator's text mininghttps://conductscience.org/library/genes/29102NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
F92158PubTator's text mininghttps://conductscience.org/library/genes/2158NCBI Gene
FLT12321PubTator's text mininghttps://conductscience.org/library/genes/2321NCBI Gene
GDE151573PubTator's text mininghttps://conductscience.org/library/genes/51573NCBI Gene
HAO154363PubTator's text mininghttps://conductscience.org/library/genes/54363NCBI Gene
HAO251179PubTator's text mininghttps://conductscience.org/library/genes/51179NCBI Gene
IL1RAPL111141PubTator's text mininghttps://conductscience.org/library/genes/11141NCBI Gene
LDLR3949PubTator's text mininghttps://conductscience.org/library/genes/3949NCBI Gene
MET4233PubTator's text mininghttps://conductscience.org/library/genes/4233NCBI Gene
MIR122406906PubTator's text mininghttps://conductscience.org/library/genes/406906NCBI Gene

See all 41 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35680378

GET https://conductscience.org/api/papers/v1/35680378/references?page=2